Forte Biosciences Inc. (NASDAQ:FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results